SLC2A1 and breast carcinoma: The process is mediated by glucose transporters (especially GLUT1) (Heydarzadeh et al., 2020), and the increased expression of GLUT1 has been linked to lower survival rates for various types of cancers, including gastric cancer, thyroid cancer, and breast cancer (Weng et al., 2022; Xu et al., 2020).